Maxim Group analyst Jason Kolbert raised his price target on Sonoma Pharmaceuticals (NASDAQ: SNOA) to $11.00 ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE